The New Sentinel Network - Improving the Evidence of Medical-Product Safety

被引：167

作者：

Platt, Richard ^{[1
,2
]}

Wilson, Marcus ^{[3
]}

Chan, K. Arnold ^{[4
]}

Benner, Joshua S. ^{[5
]}

Marchibroda, Janet ^{[6
]}

McClellan, Mark ^{[5
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA 02115 USA

[2] Harvard Pilgrim Hlth Care Inst, Boston, MA USA

[3] HealthCore, Wilmington, DE USA

[4] I3 Drug Safety, Waltham, MA USA

[5] Brookings Inst, Engelberg Ctr Hlth Care Reform, Washington, DC 20036 USA

[6] IBM Corp, Fairfax, VA USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 07期

关键词：

VACCINE;

D O I：

10.1056/NEJMp0905338

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：645 / 647

页数：3

共 3 条

[1]

[Anonymous], 2008, SENTINEL INITIATIVE

[2]

Klein N. P., 2008, Morbidity and Mortality Weekly Report, V57, P258

[3] A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study [J].

Velentgas, Priscilla ;

Bohn, Rhonda L. ;

Brown, Jeffrey S. ;

Chan, K. Arnold ;

Gladowski, Patricia ;

Holick, Crystal N. ;

Kramer, Judith M. ;

Nakasato, Cynthia ;

Spettell, Claire M. ;

Walker, Alexander M. ;

Zhang, Fang ;

Platt, Richard .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (12) :1226-1234

← 1 →